NCT05928806
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05928806
Title Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)
Acronym ARCITECT
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Michael B. Atkins, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Diego La Jolla California 92093 United States Details
Yale University, Yale Cancer Center New Haven Connecticut 06520 United States Details
Georgetown University Washington D.C. District of Columbia 20057 United States Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis Indiana 46202 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana-Farber - Partners Cancer Care, Inc Boston Massachusetts 02215 United States Details
John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
Cornell University Ithaca New York 14850 United States Details
Columbia University Irving Medical Center New York New York 10032 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Penn Medicine Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field